The Editorial Board is delighted to announce the new Cushing’s Hub Competition in which clinicians are invited to submit ideas for clinical case learning modules for healthcare professionals on the subject of Cushing’s syndrome, hypercortisolemia, and related clinical challenges. The winner will see their entry converted into an interactive educational format, with integrated vodcast, which will be promoted throughout Europe and beyond!
Treatment with the 11β-hydroxylase inhibitor osilodrostat normalizes cortisol levels in the majority of patients with Cushing’s disease, report Mônica Gadelha and co-investigators from the LINC 4 trial.
To coincide with the first anniversary of Cushing’s Hub, the Editorial Board launches the Clinical Case Competition, 28 February 2022, Rare Disease Day.
The editorial introduces the latest content on Cushing's Hub and explains the background to the exciting new Cushing's Hub Competition!